In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Sonus Pharmaceuticals Terminates Proposed Acquisition of Synt:em
SONUS PHARMACEUTICALS TO ACQUIRE FRENCH-BASED SYNT:EM, S.A.
Probiodrug and Synt:em announce collaboration
GeneMax licenses technology from NIH for vaccine for smallpox
Further licenses in Italy for LION bioscience's SRS technology
Chiron licenses Infectio Diagnostic technology for bacterial detection system
Alnylam licenses RNAi patent to Cell Signaling Technology
Debiopharm licenses-in new technology
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
